$0.89
-0.02 (-1.87%)
Open$0.98
Previous Close$0.91
Day High$0.98
Day Low$0.88
52W High$3.34
52W Low$0.59
Volume—
Avg Volume260.1K
Market Cap21.32M
P/E Ratio—
EPS$-6.56
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 35.36M | 987.4K | 951.3K |
| Net Income | -3,605,703,628 | -74,062 | -66,038 |
| Profit Margin | -374.3% | -7.5% | -6.9% |
| EBITDA | -3,494,471,712 | -123,235 | -109,691 |
| Free Cash Flow | — | -44,936 | -40,091 |
| Rev Growth | — | +23.6% | +13.9% |
| Debt/Equity | 0.01 | 1.06 | 0.89 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $465.12 | -0.42% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $168.34 | +0.23% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $538.08 | -0.84% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $955.02 | +0.40% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $164.26 | +4.86% | 7.7 | 20.98B |